Pfizer Reports Vaccine Safe for Kids Ages 5 and Older

On Monday, Sept. 20, Pfizer announced that its COVID-19 vaccine is effective in children ages 5 to 11 and said it will soon be seeking approval from the FDA to begin administering to this group. For this age group, Pfizer tested a lower dose that is one-third the strength of the adult vaccine and found that children developed antibodies just as strong as adults. Children’s is closely monitoring this developing situation and will continue to advocate and play an important role in protecting our patients and the children in our community.

Leave a Reply

Your email address will not be published. Required fields are marked *